DocuSign, Inc. (NASDAQ:DOCU) CRO Sells $1,765,622.28 in Stock

DocuSign, Inc. (NASDAQ:DOCU) CRO Loren Alhadeff sold 6,387 shares of the company’s stock in a transaction on Friday, September 17th. The shares were sold at an average price of $276.44, for a total value of $1,765,622.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Loren Alhadeff also recently made the following trade(s):

  • On Monday, July 26th, Loren Alhadeff sold 51,544 shares of DocuSign stock. The shares were sold at an average price of $306.22, for a total value of $15,783,803.68.

Shares of NASDAQ:DOCU opened at $271.16 on Wednesday. The stock has a market capitalization of $53.34 billion, a PE ratio of -315.30 and a beta of 0.84. DocuSign, Inc. has a 1 year low of $179.49 and a 1 year high of $314.76. The firm has a fifty day moving average price of $292.20 and a 200 day moving average price of $249.21. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 3.45.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings data on Wednesday, September 1st. The company reported $0.47 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.07. The firm had revenue of $511.84 million during the quarter, compared to analysts’ expectations of $487.99 million. DocuSign had a negative net margin of 9.18% and a negative return on equity of 23.08%. DocuSign’s revenue for the quarter was up 49.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.17 earnings per share. On average, sell-side analysts forecast that DocuSign, Inc. will post -0.01 earnings per share for the current fiscal year.

A number of large investors have recently modified their holdings of DOCU. Jennison Associates LLC boosted its holdings in DocuSign by 161.0% in the second quarter. Jennison Associates LLC now owns 5,126,083 shares of the company’s stock worth $1,433,099,000 after purchasing an additional 3,161,881 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in DocuSign by 24.5% during the second quarter. Price T Rowe Associates Inc. MD now owns 10,978,441 shares of the company’s stock valued at $3,069,243,000 after acquiring an additional 2,157,690 shares during the period. Morgan Stanley boosted its holdings in DocuSign by 41.1% during the second quarter. Morgan Stanley now owns 6,661,767 shares of the company’s stock valued at $1,862,430,000 after acquiring an additional 1,941,923 shares during the period. Macquarie Group Ltd. boosted its holdings in DocuSign by 1,435.2% during the second quarter. Macquarie Group Ltd. now owns 1,278,750 shares of the company’s stock valued at $357,501,000 after acquiring an additional 1,195,455 shares during the period. Finally, ARK Investment Management LLC boosted its holdings in DocuSign by 46.7% during the first quarter. ARK Investment Management LLC now owns 3,197,720 shares of the company’s stock valued at $647,378,000 after acquiring an additional 1,017,699 shares during the period. Hedge funds and other institutional investors own 75.67% of the company’s stock.

Several analysts have issued reports on DOCU shares. Oppenheimer boosted their target price on shares of DocuSign from $260.00 to $310.00 and gave the company an “outperform” rating in a research note on Friday, September 3rd. Evercore ISI boosted their target price on shares of DocuSign from $285.00 to $320.00 and gave the company an “outperform” rating in a research note on Friday, September 3rd. Needham & Company LLC boosted their target price on shares of DocuSign from $275.00 to $340.00 and gave the company a “buy” rating in a research note on Friday, September 3rd. TheStreet raised shares of DocuSign from a “d” rating to a “c-” rating in a research note on Thursday, June 3rd. Finally, Royal Bank of Canada boosted their target price on shares of DocuSign from $280.00 to $345.00 and gave the company an “outperform” rating in a research note on Friday, September 3rd. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $309.20.

DocuSign Company Profile

DocuSign, Inc provides cloud-based electronic signature solutions. Its cloud based electronic signature platform helps companies and individuals securely collect information, automate data workflows and sign anything. The firm automates manual, paper-based processes allowing users to manage all aspects of documented business transactions include identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation and storage.

Read More: What is the Russell 2000 Index?

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.